The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 190.00
Bid: 185.00
Ask: 195.00
Change: 0.00 (0.00%)
Spread: 10.00 (5.405%)
Open: 190.00
High: 190.00
Low: 190.00
Prev. Close: 190.00
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

25 Sep 2018 07:00

RNS Number : 7665B
Synectics PLC
25 September 2018
 

 

 

 

 

 

25 September 2018

 

Synectics plc

('Synectics' or 'the Company')

 

Directorate Change

 

Synectics plc (AIM: SNX), a leader in the design, integration, control and management of advanced surveillance technology and networked security systems, is pleased to announce that it has appointed Simon Beswick as Finance Director Designate, with immediate effect. On 30 November 2018, following the previously announced departure of the Company's current Finance Director, Mike Stilwell, Mr Beswick will be appointed to the Company's Board of Directors as Finance Director. This period of overlap will allow for a thorough transition of responsibilities.

 

Mr Beswick brings a varied background in large and smaller engineering and technology companies, with wide international experience in both finance and general management. Mr Beswick holds an MA in Engineering from Cambridge University and an MBA from Oxford University. He is a fellow of the Chartered Association of Certified Accountants. Until 2004 Mr Beswick was European Finance and Legal Director of Rohm & Haas (a Fortune 500 specialty chemicals company at the time listed on the NYSE). After two years as Finance Director of Midland Heart (a £130m social enterprise company), from 2007 to 2016 Mr Beswick was Finance Director and subsequently Managing Director of Tritech International, a subsidiary of FTSE 100 listed Halma plc involved in specialist subsea engineering products for the oil & gas and defence industries. He oversaw the sale of Tritech to Moog, Inc. and was retained by them to complete the post-acquisition integration. Most recently, he has provided management and accountancy advisory services and is a trustee of a £4.5 billion pension fund.

 

David Coghlan, Chairman of Synectics, commented: "I am delighted to announce Simon's appointment as Synectics' Finance Director. In addition to his wide experience as a group finance director in larger organisations, he has a solid understanding of the nuts and bolts of successful leadership of technology-based companies. These skills will strengthen Synectics' senior leadership team and we look forward to working closely with him."

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 1527 850 080

David Coghlan, Chairman

www.synecticsplc.com

email: david.coghlan@synecticsplc.com

Paul Webb, Chief Executive

Email: paul.webb@synecticsplc.com

 

Stockdale Securities Limited

Tel: +44 (0) 20 7601 6100

Tom Griffiths / Henry Willcocks

 

Appendix - AIM Rule 17

 

Save for the information set out below, there are no further disclosures to be made in accordance with Rule 17, Schedule Two (g) of the AIM Rules for Companies in respect of the appointment of Simon Beswick, aged 54. Mr Beswick does not hold an interest in the Company's share capital.

 

Current Directorships

Past Directorships

Southerndown Limited

Tritech Holdings Limited

Tritech International Limited

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUSRNRWSAKUAR
Date   Source Headline
4th Feb 20097:00 amRNSInterim Results
16th Jan 200912:06 pmRNSNotification of Results
3rd Sep 20087:00 amRNSPreliminary Results
6th Feb 20087:01 amRNSInterim Results
16th Jan 20087:00 amRNSNotification of Results
6th Dec 20071:09 pmRNSCanc of AIM trading facility
6th Dec 20079:56 amRNSOffer Update
30th Nov 20077:01 amRNSOffer Update
29th Nov 20077:01 amRNSOffer Update
26th Nov 200712:34 pmRNSResult of EGM
23rd Nov 20079:57 amRNSRule 8.1- Synexus
19th Nov 20079:40 amRNSRule 8.1- Synexus
16th Nov 200710:00 amRNSRule 8.1- Synexus
15th Nov 20073:00 pmBUSRule 8.3 - Synexus Clinincal Research Plc
15th Nov 200712:07 pmBUSRule 8.3 - Synexus Clinical Research Plc
15th Nov 20079:16 amRNSRule 8.1- Synexus
14th Nov 20073:21 pmBUSRule 8.3 - Synexus Clinical Research Plc
13th Nov 20073:16 pmBUSRule 8.3 - Synexus Clinical Research Plc
7th Nov 20074:38 pmRNSOffer Document Posted
7th Nov 20077:02 amRNSOffer for Synexus
6th Nov 20079:10 amRNSRule 8.3- Synexus
22nd Oct 200710:46 amRNSHolding(s) in Company
19th Oct 20076:21 pmRNSResponse to price movement
28th Sep 20077:02 amRNSPre Close Statement
5th Sep 20078:33 amRNSBoard Change
5th Sep 20077:01 amRNSPreliminary Results
22nd Aug 20073:17 pmRNSHolding(s) in Company
22nd Aug 200711:19 amRNSAIM RULE 26
15th Jun 20071:26 pmRNSGrant of Options
13th Jun 20077:01 amRNSPreliminary Results
24th May 20074:24 pmRNSNotice of Results
8th Mar 20077:00 amRNSHolding(s) in Company
20th Feb 200712:33 pmRNSGrant of Options
7th Feb 20077:02 amRNSNorth American Contract Wins
7th Feb 20077:02 amRNSInterim Results
6th Feb 200710:14 amRNSDirector/PDMR Shareholding
5th Feb 20077:00 amRNSDirectorate Change
29th Jan 20072:58 pmRNSNotice of Results
26th Jan 20077:01 amRNSTrading Update
28th Dec 20064:36 pmRNSGrant of Options
22nd Dec 20069:37 amRNSTotal Voting Rights & Capital
5th Dec 20067:01 amRNSInterim Results
29th Nov 20063:25 pmRNSDirector/PDMR Shareholding
24th Nov 200611:53 amRNSNotice of Results
24th Oct 20067:01 amRNSAcquisition
4th Oct 20067:00 amRNSTrading Statement
18th Sep 20069:11 amRNSDirectorate Change
13th Jul 20067:01 amRNSIssue of Equity
20th Jun 200610:39 amRNSGrant of Options
14th Jun 20065:06 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.